• News
  • BioTech

La Jolla Pharmaceutical to be listed on Nasdaq

La Jolla Pharmaceutical Co. (Nasdaq: LJPC), a developer of therapeutics targeting significant unmet life-threatening diseases, Wednesday announced that it has received approval to list its common stock on the Nasdaq Capital Market starting Wednesday.

As previously announced, in support of La Jolla Pharmaceutical's listing, the company effected a 1-for-50 reverse stock split on Jan. 13.

The company currently has 4,483,740 shares of common stock issued and outstanding; on a fully diluted basis there would be approximately 17 million shares outstanding. The ticker symbol will return back to LJPC effective with the open of trading on Wednesday.

User Response
0 UserComments